Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,547.26
(
-0.90%
)
US TECH 100
23,446.80
(
-1.16%
)
Dow Jones
45,726.19
(
-0.64%
)
Brent Oil
107.00
(
2.46%
)
Bitcoin
69,718.80
(
-0.26%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: oc631 post# 137389

Monday, 02/20/2012 12:27:25 AM

Monday, February 20, 2012 12:27:25 AM

Post# of 257262
In hindsight GS7977/riba should continue to do well in GT2/GT3 patients and in fact be the first two drug oral to market in these subgroups.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today